Visible light-activatable platinum(iv) prodrugs harnessing CD36 for ovarian cancer therapy

Amarasooriya M. D. S. Jayawardhana, Srijana Bhandari, Ariela W. Kaspi-Kaneti, Man Kshetri, Zihan Qiu, May Cheline, Hao Shen, Barry D. Dunietz and Yao-Rong Zheng

Dalton Trans., 2023, 52, 10942
DOI: 10.1039/D3DT01292A

Ligand substitution reactions afford oxaliplatin-based platinum(iv) complexes bearing axial alkoxido ligands

Zoufeng Xu, Long Lin, Binbin Fu, Fu-Ping Huang, Qiyuan Zhou, Guangyu Zhu and Zhigang Wang

Inorg. Chem. Front., 2023, 10, 6058
DOI: 10.1039/D3QI01562A

Identification of a photoredox-active Pt(IV) complex that induces light-mediated cell death

Jevon W. Marsh, Lina Hacker, Sophie A. Twigger, Jake A. Vickery, Shitong Huang, Claudia Almuzara Romero, Aaron P. Langston, Ismael Diez-Perez, Rebecca A. Musgrave, Ester M. Hammond and Adam C. Sedgwick

Chem. Sci., 2025
DOI: 10.1039/D5SC02879E

Exploring the Structure–Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs

Martijn Dijkstra, Hemma Schueffl, Barbora Adamova, Oliver Baumfried, Alexander Kastner, Walter Berger, Bernhard K. Keppler, Petra Heffeter and Christian R. Kowol

Inorg. Chem., 2025, 64, 2554
DOI: 10.1021/acs.inorgchem.4c05269

Evaluation of markers of apoptotic processes and peroxide oxidation of lipids of the mitochondrial fraction of the liver of animals carrying Lewis epidermoid carcinoma at different stages of the development of the tumor process with the introduction of organotin compounds with a tread fragment

M. S. Alhusein-Kulyaginova, M. A. Dodokhova, S. Z. Agarizaeva, S. I. Starostin, L. Y. Klimova, N. S. Silin, M. V. Gulyan, D. B. Shpakovsky, E. R. Milaeva and I. M. Kotieva

jour, 2023, 4, 89
DOI: 10.21886/2712-8156-2023-4-4-89-94

Engineering Novel Amphiphilic Platinum(IV) Complexes to Co-Deliver Cisplatin and Doxorubicin

Wjdan Jogadi, Man B. Kshetri, Suha Alqarni, Arpit Sharma, May Cheline, Md Al Amin, Cynthia Sheets, Angele Nsoure-Engohang and Yao-Rong Zheng

Molecules, 2024, 29, 4095
DOI: 10.3390/molecules29174095

Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells

Marie H. C. Boulet, Hannah R. Bolland, Ester M. Hammond and Adam C. Sedgwick

J. Am. Chem. Soc., 2023, 145, 12998
DOI: 10.1021/jacs.3c03320

Sm(Ⅲ), Gd(Ⅲ), and Eu(Ⅲ) complexes with 8‐hydroxyquinoline derivatives as potential anticancer agents via inhibiting cell proliferation, blocking cell cycle, and inducing apoptosis in NCI‐H460 cells

Kun Yang, Huan‐Qing Li, Mei‐Qi Hu, Meng‐Xue Ma, Yun‐Qiong Gu, Qi‐Yuan Yang, Muhammad Iqbal Choudhary, Hong Liang and Zhen‐Feng Chen

Drug Development Research, 2024, 85
DOI: 10.1002/ddr.22265

Water-Soluble Fluorescent Sensors for Quantification of Trace Cisplatin in Body Fluids from Clinical Cancer Patients

Zifeng Cao, Rong Yan, Jiao Chen, Mengyao She, Shanshan Jia, Wei Sun, Ping Liu, Shengyong Zhang and Jian-Li Li

J. Am. Chem. Soc., 2024, 146, 33651
DOI: 10.1021/jacs.4c10460

Supramolecular platinum complexes for cancer therapy

Wjdan Jogadi and Yao-Rong Zheng

Current Opinion in Chemical Biology, 2023, 73, 102276
DOI: 10.1016/j.cbpa.2023.102276

Exploring the Impact of Head Group Modifications on the Anticancer Activities of Fatty-Acid-like Platinum(IV) Prodrugs: A Structure–Activity Relationship Study

Man Kshetri, Wjdan Jogadi, Suha Alqarni, Payel Datta, May Cheline, Arpit Sharma, Tyler Betters, Deonya Broyles and Yao-Rong Zheng

IJMS, 2023, 24, 13301
DOI: 10.3390/ijms241713301

PEGylation Effects on Amphiphilic Platinum(IV) Complexes: Influence on Uptake, Activation, and Cytotoxicity

Arpit Sharma, Md Al Amin, Man B. Kshetri, Suha Alqarni, Wjdan Jogadi, Jordan Solmen, Zexin Lin, Shirin Akter and Yao-Rong Zheng

Pharmaceutics, 2025, 17, 440
DOI: 10.3390/pharmaceutics17040440